Dapxiga 10mg Tablet

Dapxiga 10mg Tablet contains the active ingredient Dapagliflozin and is prescribed for the management of type 2 diabetes mellitus. Dapagliflozin belongs to a class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors, which work by helping the kidneys remove glucose from the bloodstream through the urine, thereby lowering blood sugar levels.

Uses:

Dapxiga 10mg Tablet is used to improve glycemic control in adults with type 2 diabetes mellitus, either alone or in combination with other antidiabetic medications such as metformin or insulin. It helps lower blood sugar levels by increasing urinary glucose excretion and reducing the reabsorption of glucose by the kidneys.

Administration:

Dapxiga 10mg Tablet is taken orally, typically once daily in the morning with or without food, as directed by a healthcare professional. The dosage may vary depending on the patient’s medical condition, kidney function, and other factors. It is essential to follow the prescribed dosage regimen and not to adjust the dose without consulting a healthcare provider.

Side Effects:

Common side effects associated with Dapxiga 10mg Tablet may include urinary tract infections, genital yeast infections, increased urination, thirst, dizziness, and low blood pressure. Some individuals may experience more severe side effects such as dehydration, ketoacidosis (a serious condition where the body produces high levels of blood acids called ketones), and hypersensitivity reactions. It is important to seek medical attention if any unusual or severe side effects occur.

Precautions:

Before starting Dapxiga 10mg Tablet, patients should inform their healthcare provider of any medical conditions they have, especially if they have a history of kidney problems, urinary tract infections, or if they are pregnant or breastfeeding. Dapagliflozin may increase the risk of dehydration and urinary tract infections, so patients should stay hydrated and maintain good hygiene practices.

When Not to Use:

Dapxiga 10mg Tablet should not be used in individuals who are allergic to Dapagliflozin or any of its components. It is contraindicated in patients with severe kidney impairment or end-stage renal disease requiring dialysis. Dapagliflozin may interact with certain medications, so patients should inform their healthcare provider of all the medications they are taking before starting treatment.